Independent Research

In recent days, we’ve been thinking more and more about the truths in Dr. Kiessling’s 2008 article, “Philanthropy Is Key To Rapid Life Science Innovation.” Kiessling persuasively argued that over-reliance on federal funding for biomedical research can stifle innovation and put U.S. science at a disadvantage. She emphasized the historical importance of philanthropy, citing examples like the March of Dimes and the Rockefeller Foundation, in driving research forward. She contrasted the agility, long-term vision, and independence of philanthropic funding with the political restrictions and short-term priorities often associated with federal funding. She also pointed out that, from a taxpayer perspective, philanthropic dollars are more efficient. In essence, she called for tax codes and community initiatives that encourage philanthropic giving to invigorate biomedical research, leading to economic revitalization, improved health, and new business opportunities. Her central thesis remains compelling: philanthropy provides crucial support for high-risk, high-reward research, free from many of the pressures faced by government and industry. We believe these arguments are even more relevant today.